At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Detection of Sentinel Lymph Nodes in Female Lower Genital Tract Cancer Patients With Contrast-Enhanced Ultrasound Imaging
In Brief
A Early Phase 1 clinical trial evaluating Perflubutane Microbubble and Contrast-Enhanced Ultrasound for Cervical Carcinoma and 3 related conditions. Completed, enrolled 9 participants across 1 site.
Detailed Summary
This clinical trial compares the use of ultrasound for the detection of sentinel lymph nodes (SLNs) to the standard of care (which varies depending on cancer treatment). The ultrasound contrast agent is called Sonazoid and it consists of tiny gas-filled bubbles about the side of red blood cells. Diagnostic procedures, such as ultrasound with Sonazoid, may help identify more SLNs than standard of care in patients with cervical, vaginal, or vulvar cancer.
Study Details
Timeline
Interventions
Given subdermally
Undergo ultrasound